Albert Luderer
Interim Chief Executive, Director · Bionano Genomics, Inc.
IndividualBuying only
- 2026
- Sep 9, 2026
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Albert Luderer's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- BCP 8 Holdings Mozart Manager L.L.C. - $2.35B in MDLN purchases and sales in the last 12 months
- LILLY ENDOWMENT INC - $2.23B in LLY purchases and sales in the last 12 months
- KKR Phoenix Aggregator L.P. - $2.09B in BTSG purchases and sales in the last 12 months
- KKR Group Partnership L.P. - $2.09B in BTSG purchases and sales in the last 12 months
- GIC Private Ltd - $1.81B in MDLN purchases and sales in the last 12 months
- Carlyle Group Inc. - $1.63B in MDLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Albert Luderer?
Albert Luderer is a corporate insider, tracked as Interim Chief Executive, Director of Bionano Genomics, Inc. (BNGO). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Albert Luderer submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Albert Luderer been buying or selling stock?
Recorded transactions: 2 open-market purchases ($10K) and 0 open-market sales across all tracked filings.
